Next Generation Potency Testing –Moving from Surface Markers and Flow Cytometry to Omics Approaches

Time: 2:00 pm
day: Day One


  • Multiple assays using orthogonal techniques to measure different aspects of potency are often necessary for cell therapy drug products
  • Phase appropriate considerations in assay development using surface markers and omics approaches
  • Utilizing omics in early stages may lead to better understanding of mechanism of action and drug products